BALYASNY ASSET MANAGEMENT L.P. - 31 Dec 2025 SCHEDULE 13G/A Report for Avalo Therapeutics Inc. Common Stock, par value $0.001 per share (AVTX)

Filing Manager
BALYASNY ASSET MANAGEMENT L.P.
Reporting Manager
Balyasny Asset Management L.P.
Security
Avalo Therapeutics Inc. Common Stock, par value $0.001 per share
Symbol
AVTX
Shares outstanding
18,153,388 shares
Disclosed Ownership
439,312 shares
Ownership
2.4%
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 06:57:14 UTC
Date of event
31 Dec 2025
Previous filing
14 Nov 2025
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Balyasny Asset Management L.P. 2.4% 439,312 439,312 0 /s/ Scott Schroeder Scott Schroeder / Authorized Signatory
BAM GP LLC 2.4% 439,312 439,312 0 /s/ Scott Schroeder Scott Schroeder / Authorized Signatory
Balyasny Asset Management Holdings LP 2.4% 439,312 439,312 0 /s/ Scott Schroeder Scott Schroeder / Authorized Signatory
Dames GP LLC 2.4% 439,312 439,312 0 /s/ Scott Schroeder Scott Schroeder / Authorized Signatory
Dmitry Balyasny 2.4% 439,312 439,312 0 /s/ Dmitry Balyasny Dmitry Balyasny / Self